In consideration of the emerging local outbreak of Zika virus infection, the FDA recommended that all blood establishments in Miami-Dade County cease collecting blood immediately until they implement testing of each individual unit of blood collected in the county for Zika virus RNA or until the blood establishments implement the use of an approved or investigational pathogen inactivation technology.
Additionally, the agency recommended that adjacent and nearby counties also